ID

43530

Description

Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00467740

Link

https://clinicaltrials.gov/show/NCT00467740

Keywords

Versions (2)
  1. 4/12/16 4/12/16 -
  2. 9/20/21 9/20/21 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00467740

English

Eligibility Asthma NCT00467740

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00467740
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. all patients must sign an informed consent consistent with ich-gcp guidelines prior to participation in the trial, which includes medication washout and restrictions
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. male or female patients, 18 years of age or older
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. diagnosis of asthma (gina)
Description

asthma

Data type

boolean

Alias
UMLS CUI [1]
C0004096
4. pre-bronchodilator fev1 greater than or equal to 60% predicted and <90% predicted (ecsc);
Description

pre-bronchodilator fev1

Data type

boolean

Alias
UMLS CUI [1]
C3172227
5. increase in fev1 greater than or equal to 12% and 200 ml 15 minutes after 400µg salbutamol (albuterol) at visit 1
Description

fev1 salbutamol

Data type

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0001927
6. patient must have been taking inhaled corticosteroids for at least 12 weeks prior to screening, and must have been receiving a stable low/moderate dose for at least 6 weeks prior to screening.
Description

inhaled corticosteroids

Data type

boolean

Alias
UMLS CUI [1,1]
C2065041
UMLS CUI [1,2]
C0040223
7. patients must be able to perform technically acceptable pulmonary function tests and pef measurements, and must be able to maintain records (patient daily e-diary) during the study period as required in the protocol
Description

pulmonary function tests and pef measurement

Data type

boolean

Alias
UMLS CUI [1]
C0024119
UMLS CUI [2]
C0521299
8. patients must be able to inhale medication in a competent manner from the respimat®
Description

respimat

Data type

boolean

inhaler and from a metered dose inhaler (mdi).
Description

metered dose inhaler

Data type

boolean

Alias
UMLS CUI [1,1]
C0993596
UMLS CUI [1,2]
C1524063
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with a smoking history of more than 10 pack years
Description

smoking history

Data type

boolean

Alias
UMLS CUI [1,1]
C1519384
UMLS CUI [1,2]
C1277691
2. patients with any of the following conditions: a diagnosis of thyrotoxicosis, a diagnosis of paroxysmal tachycardia (>100 beats per minute), a marked baseline prolongation of qt/qtc interval (e.g., repeated demonstration of a qtc interval >450 ms), a history of additional risk factors for torsade de pointes (tdp) (e.g., heart failure, hypokalemia, family history of long qt syndrome)
Description

a diagnosis of thyrotoxicosis, a diagnosis of paroxysmal tachycardia (>100 beats per minute), a marked baseline prolongation of qt/qtc interval (e.g., repeated demonstration of a qtc interval >450 ms), a history of additional risk factors for torsade de pointes (tdp) (e.g., heart failure, hypokalemia, family history of long qt syndrome)

Data type

boolean

Alias
UMLS CUI [1]
C0040156
UMLS CUI [2]
C0039236
UMLS CUI [3]
C4478837
UMLS CUI [4,1]
C0040479
UMLS CUI [4,2]
C0035648
3. patients with any of the following conditions: a history of myocardial infarction within 1 year of screening visit (visit 1), a diagnosis of clinically relevant cardiac arrhythmia, a history of cor pulmonale, known active tuberculosis, a malignancy for which patient has undergone resection, radiation therapy or chemotherapy within last five years (patients with treated basal cell carcinoma are allowed), a history of life-threatening pulmonary obstruction, a history of cystic fibrosis, clinically evident bronchiectasis, a history of significant alcohol or drug abuse
Description

a history of myocardial infarction within 1 year of screening visit (visit 1), a diagnosis of clinically relevant cardiac arrhythmia, a history of cor pulmonale, known active tuberculosis, a malignancy for which patient has undergone resection, radiation therapy or chemotherapy within last five years (patients with treated basal cell carcinoma are allowed), a history of life-threatening pulmonary obstruction, a history of cystic fibrosis, clinically evident bronchiectasis, a history of significant alcohol or drug abuse

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0003811
UMLS CUI [3]
C0034072
UMLS CUI [4]
C0041296
UMLS CUI [5]
C0006826
UMLS CUI [6,1]
C0001883
UMLS CUI [6,2]
C2826244
UMLS CUI [7]
C0010674
UMLS CUI [8]
C0006267
UMLS CUI [9]
C0038586
4. patients who have undergone thoracotomy with pulmonary resection
Description

thoracotomy with pulmonary resection

Data type

boolean

Alias
UMLS CUI [1,1]
C0039991
UMLS CUI [1,2]
C0396565
5. patients who have taken an investigational drug within one month or six half lives (whichever is greater) prior to screening visit (visit 1)
Description

investigational drug

Data type

boolean

Alias
UMLS CUI [1]
C0013230
6. pregnant or nursing women
Description

pregnancy or lactation

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
7. women of childbearing potential not using a highly effective method of birth control. female patients will be considered to be of childbearing potential unless surgically sterilised by hysterectomy or bilateral tubal ligation, or post-menopausal for at least 2 years
Description

childbearing potential and contraception

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0700589
8. patients who have previously been randomized in this study or are currently participating in another study
Description

participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
9. patients who are unable to comply with pulmonary medication restrictions prior to randomization
Description

compliance

Data type

boolean

Alias
UMLS CUI [1]
C1321605
Back to the top of the page

Similar models

Eligibility Asthma NCT00467740

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00467740
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
1. all patients must sign an informed consent consistent with ich-gcp guidelines prior to participation in the trial, which includes medication washout and restrictions
boolean
C0021430 (UMLS CUI [1])
age
Item
2. male or female patients, 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
asthma
Item
3. diagnosis of asthma (gina)
boolean
C0004096 (UMLS CUI [1])
pre-bronchodilator fev1
Item
4. pre-bronchodilator fev1 greater than or equal to 60% predicted and <90% predicted (ecsc);
boolean
C3172227 (UMLS CUI [1])
fev1 salbutamol
Item
5. increase in fev1 greater than or equal to 12% and 200 ml 15 minutes after 400µg salbutamol (albuterol) at visit 1
boolean
C0748133 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
inhaled corticosteroids
Item
6. patient must have been taking inhaled corticosteroids for at least 12 weeks prior to screening, and must have been receiving a stable low/moderate dose for at least 6 weeks prior to screening.
boolean
C2065041 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pulmonary function tests and pef measurement
Item
7. patients must be able to perform technically acceptable pulmonary function tests and pef measurements, and must be able to maintain records (patient daily e-diary) during the study period as required in the protocol
boolean
C0024119 (UMLS CUI [1])
C0521299 (UMLS CUI [2])
respimat
Item
8. patients must be able to inhale medication in a competent manner from the respimat®
boolean
metered dose inhaler
Item
inhaler and from a metered dose inhaler (mdi).
boolean
C0993596 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
smoking history
Item
1. patients with a smoking history of more than 10 pack years
boolean
C1519384 (UMLS CUI [1,1])
C1277691 (UMLS CUI [1,2])
a diagnosis of thyrotoxicosis, a diagnosis of paroxysmal tachycardia (>100 beats per minute), a marked baseline prolongation of qt/qtc interval (e.g., repeated demonstration of a qtc interval >450 ms), a history of additional risk factors for torsade de pointes (tdp) (e.g., heart failure, hypokalemia, family history of long qt syndrome)
Item
2. patients with any of the following conditions: a diagnosis of thyrotoxicosis, a diagnosis of paroxysmal tachycardia (>100 beats per minute), a marked baseline prolongation of qt/qtc interval (e.g., repeated demonstration of a qtc interval >450 ms), a history of additional risk factors for torsade de pointes (tdp) (e.g., heart failure, hypokalemia, family history of long qt syndrome)
boolean
C0040156 (UMLS CUI [1])
C0039236 (UMLS CUI [2])
C4478837 (UMLS CUI [3])
C0040479 (UMLS CUI [4,1])
C0035648 (UMLS CUI [4,2])
a history of myocardial infarction within 1 year of screening visit (visit 1), a diagnosis of clinically relevant cardiac arrhythmia, a history of cor pulmonale, known active tuberculosis, a malignancy for which patient has undergone resection, radiation therapy or chemotherapy within last five years (patients with treated basal cell carcinoma are allowed), a history of life-threatening pulmonary obstruction, a history of cystic fibrosis, clinically evident bronchiectasis, a history of significant alcohol or drug abuse
Item
3. patients with any of the following conditions: a history of myocardial infarction within 1 year of screening visit (visit 1), a diagnosis of clinically relevant cardiac arrhythmia, a history of cor pulmonale, known active tuberculosis, a malignancy for which patient has undergone resection, radiation therapy or chemotherapy within last five years (patients with treated basal cell carcinoma are allowed), a history of life-threatening pulmonary obstruction, a history of cystic fibrosis, clinically evident bronchiectasis, a history of significant alcohol or drug abuse
boolean
C0027051 (UMLS CUI [1])
C0003811 (UMLS CUI [2])
C0034072 (UMLS CUI [3])
C0041296 (UMLS CUI [4])
C0006826 (UMLS CUI [5])
C0001883 (UMLS CUI [6,1])
C2826244 (UMLS CUI [6,2])
C0010674 (UMLS CUI [7])
C0006267 (UMLS CUI [8])
C0038586 (UMLS CUI [9])
thoracotomy with pulmonary resection
Item
4. patients who have undergone thoracotomy with pulmonary resection
boolean
C0039991 (UMLS CUI [1,1])
C0396565 (UMLS CUI [1,2])
investigational drug
Item
5. patients who have taken an investigational drug within one month or six half lives (whichever is greater) prior to screening visit (visit 1)
boolean
C0013230 (UMLS CUI [1])
pregnancy or lactation
Item
6. pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
childbearing potential and contraception
Item
7. women of childbearing potential not using a highly effective method of birth control. female patients will be considered to be of childbearing potential unless surgically sterilised by hysterectomy or bilateral tubal ligation, or post-menopausal for at least 2 years
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
participation status
Item
8. patients who have previously been randomized in this study or are currently participating in another study
boolean
C2348568 (UMLS CUI [1])
compliance
Item
9. patients who are unable to comply with pulmonary medication restrictions prior to randomization
boolean
C1321605 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial